Berman Lab at the SCRI
Refining clinical targets, changing patient lives.
We discover and evaluate novel biomarkers and therapeutic targets to improve the lives of patients with bladder and prostate cancer. Integrating information from massive genomic databases, our own experimental studies, and carefully curated human biospecimens, our powerful approach creates results. We have ongoing projects developing and refining a wide variety of biomarkers to guide clinical management.
Molecular and image-based biomarkers that guide patient care
Image analysis paired with bioinformatics and machine learning
Combining genomics, epigenomics, and proteomics
Our mission
We train the next generation of cancer researchers while developing diagnostic and prognostic tests to guide cancer management.
Our students learn about cancer: how to diagnose it, how it grows and spreads, and how it is treated. They also learn how to study it, using a variety of powerful data analysis techniques. It all comes together in designing new ways to improve cancer care.
We work in an interdisciplinary team environment, integrating data scientists, pathologists, urologists, industry partners with whom we are developing commercial image analysis algorithms for research and clinical use, and other scientists and doctors as required.
